工信部：加快关键核心技术攻关 增强医药产业链韧性和安全水平

Core Points - The meeting organized by the Ministry of Industry and Information Technology emphasized the direction and fundamental guidelines for the high-quality development of the pharmaceutical industry during the 14th Five-Year Plan and beyond [2] - The industry is urged to consolidate the stable recovery of pharmaceutical operations, accelerate key core technology breakthroughs, enhance the resilience and safety of the pharmaceutical supply chain, and strengthen the supply of innovative drugs and medical devices to meet the growing health demands of the public [2] Summary by Sections Meeting Overview - The meeting focused on the operational status of the pharmaceutical industry, statistical surveys, high-quality development of the industrial chain, and the preparation of the 14th Five-Year Plan for the pharmaceutical industry [1][2] - Participants included local industrial and information authorities, industry associations, subordinate institutions, and supporting organizations [1] Strategic Directions - The meeting highlighted the need for the industry to learn and implement the spirit of the 20th National Congress, accurately grasp changes in internal and external situations, and promote a transition from scale expansion to innovation-driven development [2] - It called for the establishment of a robust work mechanism, strengthening statistical survey foundations, and ensuring data authenticity to support industry management [2] Development Initiatives - The meeting emphasized the importance of systematic planning for the 14th Five-Year Plan, focusing on key areas, and fostering new productive forces in the pharmaceutical industry [2] - It encouraged strengthening supply-demand connections, leveraging existing platforms for resource sharing, and promoting collaboration across the industry chain [2] - The meeting advocated for the promotion of innovative pharmaceutical achievements and the application of innovative drugs and devices, creating a favorable ecosystem for innovation in the pharmaceutical industry [2]